Karnawati Innovation Reports Strong Q3FY26 Results with Revenue of ₹7,146.89 Lakhs

1 min read     Updated on 13 Feb 2026, 04:46 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Karnawati Innovation Limited announced robust Q3FY26 financial results with revenue of ₹7,146.89 lakhs and net profit of ₹184.53 lakhs, representing substantial growth from previous quarters. The nine-month cumulative performance showed total revenue of ₹9,265.29 lakhs and net profit of ₹362.26 lakhs, marking a significant turnaround from the previous year's loss.

powered bylight_fuzz_icon
32356356

*this image is generated using AI for illustrative purposes only.

Karnawati Innovation Limited has announced its unaudited standalone financial results for the third quarter ended December 31, 2025, showing significant operational performance. The Board of Directors approved these results during their meeting held on February 13, 2026, in compliance with SEBI regulations.

Financial Performance Overview

The company reported robust financial metrics for Q3FY26, demonstrating substantial growth in operations. The quarterly results reflect the company's improved business performance compared to previous periods.

Metric: Q3FY26 Q2FY26 Q3FY25
Revenue from Operations: ₹7,146.89 lakhs ₹2,000.42 lakhs -
Net Profit: ₹184.53 lakhs ₹161.48 lakhs (₹0.63 lakhs)
Basic EPS: ₹0.342 ₹0.299 (₹0.001)
Total Expenses: ₹6,962.36 lakhs ₹1,838.94 lakhs ₹0.63 lakhs

Nine-Month Cumulative Performance

For the nine months ended December 31, 2025, the company achieved remarkable growth with total revenue reaching ₹9,265.29 lakhs compared to ₹47.19 lakhs in the corresponding period of the previous year. The cumulative net profit stood at ₹362.26 lakhs, a significant improvement from the loss of ₹7.14 lakhs in the previous year.

Parameter: 9M FY26 9M FY25
Total Revenue: ₹9,265.29 lakhs ₹47.19 lakhs
Net Profit/(Loss): ₹362.26 lakhs (₹7.14 lakhs)
Basic EPS: ₹6.70 (₹0.13)

Cost Structure and Operational Efficiency

The company's cost structure shows that material consumption constituted the major expense component at ₹6,951.93 lakhs for Q3FY26. Employee benefit expenses remained controlled at ₹3.20 lakhs, while other expenses were ₹7.20 lakhs for the quarter.

Regulatory Compliance and Audit

The financial results have been reviewed by A.L. Thakkar & Co., Chartered Accountants, who issued a limited review report. The results were prepared in accordance with Indian Accounting Standard 34 and comply with SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. The Board meeting commenced at 3:00 PM and concluded at 3:30 PM on February 13, 2026.

Company Information

Bisil Plast , operating under CIN L17119GJ1986PLC009009, maintains its registered office at Office No. 702/3, 7th Floor, Shilp Aaron, Sindhubhavan Road, Thaltej, Ahmedabad, Gujarat. The company operates in a single business segment, and the results are available on both the company website and BSE Limited's website for stakeholder reference.

Karnawati Innovation Postpones Rights Issue Committee Meeting Pending Exchange Approval

2 min read     Updated on 30 Dec 2025, 03:46 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Karnawati Innovation Limited has postponed its Rights Issue Committee meeting that was scheduled for December 30, 2025, as the company awaits in-principle approval from the stock exchange for its ₹49 crore rights issue. The meeting, which was intended to finalize key terms including record date, issue price, and entitlement ratio, will now be held within the next working day following receipt of the regulatory approval.

powered bylight_fuzz_icon
28100717

*this image is generated using AI for illustrative purposes only.

Karnawati Innovation Limited has postponed its Rights Issue Committee meeting that was scheduled for December 30, 2025, pending receipt of in-principle approval from the stock exchange. The company had earlier announced board approval for a rights issue aimed at raising funds up to ₹49.00 crores during a board meeting held on December 24, 2025.

Rights Issue Details

The board had approved the issuance and allotment of equity shares with the following parameters:

Parameter: Details
Face Value: ₹1.00 per equity share
Maximum Amount: ₹49.00 crores
Issue Type: Rights issue basis
Eligibility: Existing equity shareholders
Record Date: To be notified subsequently
Meeting Duration: 10:00 AM to 10:45 AM

The rights issue will be offered to eligible equity shareholders of the company as on the record date, which will be announced later. The issue will be conducted subject to receipt of applicable regulatory and statutory approvals.

Committee Meeting Postponement

The Rights Issue Committee meeting was originally scheduled to consider and approve various matters including fixing the record date, issue price, entitlement ratio, and other terms and conditions related to the rights issue. However, the company has now postponed the meeting due to pending regulatory approvals:

Meeting Status: Information
Original Date: December 30, 2025
Status: Postponed
Reason: Pending in-principle approval from stock exchange
New Timeline: Within next working day post approval receipt
Agenda: Record date, issue price, entitlement ratio

The meeting will now be held within the next working day following receipt of the in-principle approval letter from the stock exchange for the rights issue.

Rights Issue Committee Composition

To oversee the rights issue process, the board had constituted a Rights Issue Committee with three members:

Position: Name
Chairman: Mr. Ravikumar Kirtibhai Patel
Member: Mrs. Nidhiben Ravindrakumar Joshi
Member: Mr. Vatsal Sanjaybhai Patel

Mr. Ravikumar Kirtibhai Patel, who serves as the Managing Director with DIN: 11018966, chairs the committee and has been granted authority to appoint various intermediaries and execute all necessary actions for the rights issue.

Trading Window Status

In compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015 and the company's Code of Conduct, the trading window for dealing in securities remains closed from December 24, 2025. The window will remain closed until 48 hours from the closure of the Rights Issue Committee meeting.

Regulatory Framework

The rights issue will be conducted in accordance with the Companies Act, 2013, Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and other applicable laws. The board has also approved the Draft Letter of Offer and other relevant documents to be filed with BSE Limited.

More News on Karnawati Innovation